Key statistics
On Monday, Ionis Pharmaceuticals Inc (0JDI:LSE) closed at 35.93, 7.10% above its 52-week low of 33.55, set on Nov 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 35.93 |
Low | 35.93 |
Bid | -- |
Offer | -- |
Previous close | 34.53 |
Average volume | 4.03k |
---|---|
Shares outstanding | 157.90m |
Free float | 156.69m |
P/E (TTM) | -- |
Market cap | 5.37bn USD |
EPS (TTM) | -2.45 USD |
Data delayed at least 20 minutes, as of Nov 25 2024 16:12 GMT.
More ▼
Press releases
- Ionis to present at upcoming investor conferences
- Ionis Announces Pivotal Phase 3 Trial Design for ION582 in Angelman Syndrome
- Ionis reports third quarter 2024 financial results
- Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE
- Ionis to hold third quarter 2024 financial results webcast
- WAINZUA (eplontersen) recommended for approval in the EU by CHMP for the treatment of adults with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis
- New positive donidalorsen data to be presented at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
- Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
- Ionis announces pricing of $500.3 million public offering
- Ionis announces proposed public offering of common stock
More ▼